Nov 14 (Reuters)-
Cyfuse Biomedical K.K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2025 Sep 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 61 mln 26 mln 302 mln
(+135.5 pct) (-11.5 pct) (+455.8 pct)
Operating loss 689 mln loss 674 mln loss 1.22
Recurring loss 635 mln loss 662 mln loss 1.14
Net loss 637 mln loss 664 mln loss 1.14
EPS loss 74.69 yen loss 82.80 yen loss 139.64 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Cyfuse Biomedical K.K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T